Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey

Patients can access weight management care for $49 per visit, no monthly subscription needed

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens announced today the launch of Walgreens Weight Management, a new digital healthcare offering designed to help eligible adults access personalized, clinician-guided support for weight loss. This expands Walgreens’ Virtual Healthcare platform and provides patients with convenient access to licensed doctors and nurse practitioners, FDA-approved medication options and ongoing support from the comfort of their home. The program is intended for eligible overweight and obese adults ages 18-64 who plan to self-pay for their GLP-1 medication.

As part of the new program, eligible patients can complete an online video visit with a licensed doctor or nurse practitioner who evaluates their health history, weight related goals and medical needs. Providers may prescribe FDA-approved GLP-1s for weight loss for eligible overweight or obese patients that are starting or continuing their weight loss journey using a GLP-1. The program offers on-demand follow-up visits via chat or video for medication adjustments and side effect management between 7 a.m. and 11 p.m. CT, 7 days a week.

Walgreens has also expanded its Rx Savings Finder tool, powered by RxSense, to include Novo Nordisk’s reduced price starting at $149 per month for the recently launched Wegovy ® (semaglutide) 1.5 mg or 4 mg tablet and $199 per month for the Wegovy ® 0.25 mg and 0.5 mg injectable.¹ Learn about the terms and conditions of this reduced price offer on the Walgreens Weight Management page here.

“Expanding our virtual healthcare platform to include weight management is part of our ongoing commitment to listening to patients and the services they want from their local pharmacy,” said Rick Gates, Chief Pharmacy Officer, Walgreens. “By combining trusted clinical expertise with the reach of our digital and pharmacy network, we’re helping eligible patients take meaningful steps toward better health, on their own terms.”

Less than 1 in 4 employers surveyed by KFF in 2025 covered GLP-1s for weight loss when used primarily for weight management.² Walgreens Weight Management is a more affordable option than other telehealth subscriptions for patients who do not have GLP-1 coverage via their employers.

The program is accessible in most states and is designed to integrate seamlessly with Walgreens’ pharmacy services. Patients can send their prescription to the pharmacy of their choice. All visits are $49 with no monthly subscription needed.

Patients interested in learning more about Walgreens Weight Management and/or determining eligibility can do so here: Walgreens Weight Management.

Currently available in the following states: AZ, CA, CO, CT, FL, GA, IL, IN, KS, KY, MA, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OK, PA, SC, TN, TX, VA, WA, WI.

Wegovy ® (semaglutide) is a prescription medication.

Wegovy^® may cause serious side effects, including:

• Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy^® and other medicines that work like Wegovy^® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy^® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Do not use Wegovy^® if:

• you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy^® injection or Wegovy^® tablets.

The most common side effects of Wegovy^® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.^[1]

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

About Walgreens

Founded in 1901, Walgreens (www.walgreens.com) proudly serves more than 9 million customers and patients each day across its nearly 8,000 stores throughout the U.S. and Puerto Rico. Walgreens has approximately 211,000 team members, including roughly 85,000 healthcare service providers, and is committed to being the first choice for pharmacy, retail and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.

References:

1 Wegovy prescribing information: https://www.novo-pi.com/wegovy.pdf

2 Kaiser Family Foundation. (2025, October 22). 2025 Employer Health Benefits Survey. Kaiser Family Foundation. https://www.kff.org/health-costs/2025-employer-health-benefits-survey/

Contacts

Media Contact
Carmen Lopez
[e-mail]